A study of dedifferentiated liposarcoma found that high levels of MDM2 amplification (>38 copies) and CDK4 amplification (>30 copies) were correlated with reduced disease-free survival (DFS) and disease-specific survival (DSS) [92]. Here, MDM2 is linked to liposarcoma.